Possibility and prospects of using colchicine in patients with COVID-19, review update


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

There are theoretical prerequisites for the use of colchicine in the treatment of patients with COVID-19, and clinical studies are underway. To date, there is only limited published data indicating the potential efficacy of colchicine for COVID-19. These data do not yet allow to recommend it for general practice. When using colchicine, it is important to perform clinical and hematologic control and avoid drug interactions.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

Yu. Kiselev

Oslo Metropolitan University

Norway

A. Matveev

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

Әдебиет тізімі

  1. URL: https://gris.rosminzdrav.ru/.
  2. URL: https://www.medicines.org.uk/emc/ product/6415/smpc.
  3. Misawa T, Takahama M., Kozaki T., et ai. Microtubuie-driven spatial arrangement of mitochondria promotes activation of the NLRP3 infiammasome. Nat Immunoi. 2013;14:454-60.
  4. Hemkens L.G., Ewaid H, Gioy V.L., et ai. Coichicine for prevention of cardiovascuiar events. Cochrane Database Syst Rev. 2016;1:CD011047. doi: 10.1002/14651858.CD011047.pub2.
  5. Tardif J.C., Kouz S, Waters D.D., et ai. Efficacy and Safety of Low-Dose Coichicine after Myocardiai Infarction. N Engi J Med. 2019;381(26):2497-505. doi: 10.1056/NEJMoa1912388.
  6. Leung Y.Y., Hui L.L.Y, Kraus V.B. Coichicine-update on mechanism of action and therapeutic uses. Semin Arthr Rheum. 2015;45:341-50. doi: 10.1016/j.semarthrit.2015.06.013.
  7. Miiewska A., Nowak P, Owczarek K., et ai. Entry of human coronavirus NL63 into the ceil. J Virol. 2018;92:e01933-17. Doi: 10.1128/ JVi.01933-17.
  8. Guitekin N, Kucukates E. Microtubule inhibition therapy by colchicine in severe myocarditis especially caused by Epstein-Barr and cytomegalovirus co-infection during a two-year period: a novel therapeutic approach. J Pak Med Assoc. 2014;64:1420-23.
  9. Piantoni S., Patroni A., Toniati P, et al. Why not to use colchicine in COViD-19? An old antiinflammatory drug for a novel auto-inflammatory disease [published online ahead of print, 2020 May 30]. Rheumatol. (Oxford). 2020;keaa217. doi: 10.1093/rheumatobgy/keaa217.
  10. Nasiripour S., Zamani F, Farasatinasab M. Can Colchicine as an Old Anti-inflammatory Agent Be Effective in COViD-19? [Publish on-line ahead of print, 2020 May 23]. J Clin Pharmacol. 2020; 10:1002/jcph. 1 645. Doi: 10.1002/ jcph.1645.
  11. URL: https://covid19evidence.net.au/.
  12. URL: https://www.covid19treatmentguidelines. nih.gov/
  13. URL: https://static-0.minzdrav.gov.ru/system/ attachments/attaches/000/054/662/original/% D0%92%D1%80%D0%B5%D0%BC%D0%B5% D0%BD%D0%BD%D1%8B%D0%B5_%D0%9C %D0%A0_COViD-19_%28v.10%29.pdf.
  14. URL: https://www.canada.ca/en/public-health/ services/diseases/2019-novel-coronavirus-infection/ciinicai-management-covid-19.htmi.
  15. URL: https://www.ncbi.nlm.nih.gov/pmc/artides/ PMC7097833/pdf/idr-12-1-8543.pdf.
  16. URL: http://mc.msu.ru/protokol-COViD-MNOC. pdf?fbdid=iwAR0pcfEk_LpYL8O6YKNGEbe3b_ FuEpYTbiap8JTH6ZhnVjYLzTFtHBKpYNY
  17. Della-Torre E., Della-Torre F, Kusanovic Pcp M., et al. Treating COViD-19 with colchicine in community healthcare setting [Publish. On-line ahead of print, 2020 May 31]. Clin immunol. 2020;108490. doi: 10.1016/j.clim.2020.108490.
  18. Cumhur Cure M., Kucuk A., Cure E. Colchicine may not be effective in COViD-19 infection; it may even be harmful? [Publish. on-line ahead of print, 2020 May 11]. Clin Rheumatol. 2020;1-2. doi: 10.1007/s10067-020-05144-x.
  19. Gendelman O., Amital H., Bragazzi N.L., et al. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS- CoV-2: insights from a large healthcare database analysis. Autoimmun Rev. 2020;19(7):102566. doi: 10.1016/j.autrev.2020.102566.
  20. URL: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ colchicine-marketed-colcrys-information.
  21. URL: https://dinicaitriais.gov/ct2/resuits?co nd=COViD&term=colchicine&cntry=&state= &city=&dist=.
  22. Reyes A.Z., Hu K.A., Teperman J., et alAnti-inflammatory therapy for COViD-19 infection: the case for colchicine. Ann Rheum Dis. [Publish on-line First: 08 December 2020.]. Doi: 10.1136/ annrheumdis-2020-219174.
  23. URL: https://www.medrxiv.org/content/10.1101 /2021.01.26.21250494v1.full.pdf.
  24. Lopes M.i., Bonjorno L.P, Giannini M.C., et alBeneficial effects of colchicine for moderate to severe COViD-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open. 2021;7:e001455. Doi: 10.1136/ rmdopen-2020-001455.
  25. URL: https://www.recoverytrial.net/news/ colchicine-to-be-investigated-as-a-possible-treatment-for-covid-19-in-the-recovery-trial.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2021

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>